Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

NCT00049036 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

NIH

Sponsor class

Conditions

AIDS-related Diffuse Large Cell Lymphoma
AIDS-related Immunoblastic Large Cell Lymphoma
AIDS-related Peripheral/Systemic Lymphoma
AIDS-related Small Noncleaved Cell Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: etoposide
DRUG: doxorubicin hydrochloride
DRUG: vincristine sulfate
DRUG: prednisone
DRUG: cyclophosphamide
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)